News Release VacciXcell



ISCT 2017


May 08, 2017


VacciXcell participated in the recently concluded ISCT 2017 held at ExCel London, United Kingdom last May 3-6, 2017. ISCT 2017 marks the 25th Anniversary of the International Society for Cellular Therapy. VacciXcell displayed their tide motion bioreactor systems which are perfect for cell proliferation such as those utilized in cellular therapy.

VacciXcell Booth with CelCradleTM Lab Scale Adherent Bioreactor

VacciXcell TideCell® Pilot/Production Scale Bioreactor

Tide motion bioreactors utilizes the proprietary tide motion technology which allows it to be the lowest cost, highest yield adherent bioreactor while also being truly linearly scalable. The tide motion bioreactor systems generated a lot of interest from the visitors during the exhibit.

VacciXcell thanks all the organizers, participants and attendees for making ISCT 2017 a huge success. Watch out for more VacciXcell events!